Search clinical trials for: Growth Inhibitors

Total 65141 results

Alkahest, Inc.

Completed

A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD (PHTHALO-205)

Neovascular Age-related Macular Degeneration

United States, Germany, Poland, Hungary
Bioeq GmbH

Completed

Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration (COLUMBUS-AMD)

Age-related Macular Degeneration (AMD)

France, Italy, Poland, Russian Federation, Spain, United Kingdom, Germany, Hungary, Ukraine, Austria, Czechia, Israel
Universiti Sains Malaysia

Completed

Effects of Ranibizumab in Primary Pterygium Surgery

Patients With Primary Nasal Pterygium

Malaysia
Novartis Pharmaceuticals

Terminated

Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase (CONSTELLATION)

Diabetes | Macular Degeneration | Macular Edema

France
Moorfields Eye Hospital NHS Foundation Trust
Novartis

Completed

Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study (RaDiVit)

Diabetic Retinopathy | Retinal Neovascularisation

United Kingdom
Federico II University

Completed

Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab

Coats Disease

Italy
University of California, San Diego
Genentech, Inc.

Terminated

Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab (COMPASS)

Age-Related Macular Degeneration

United States
Novartis Pharmaceuticals

Completed

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. (ECLIPSE)

Diabetic Retinopathy | Macular Edema | Choroidal Neovascularization | Glaucoma, Neovascular

France
Jumper, J. Michael, M.D.
Genentech, Inc.

Terminated

Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)

Macular Edema | Proliferative Diabetic Retinopathy

United States
Northern California Retina Vitreous Associates
Genentech, Inc.

Completed

Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept. (RESCUE)

Recalcitrant Wet Age-related Macular Degeneration

United States
Dartmouth-Hitchcock Medical Center
Celgene Corporation

Terminated

Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance (MGUS)

Neuropathy | Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)

United States
Southeast Clinical Research Associates, LLC
Regeneron Pharmaceuticals

Withdrawn

Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab

Diabetic Macular Edema

United States
University of Cologne

Unknown

Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD (RESPONSE)

Macular Degeneration

Germany
Regeneron Pharmaceuticals
National Cancer Institute (NCI)

Completed

VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Lymphoma | Unspecified Adult Solid Tumor, Protocol Specific

United States
Novartis

Completed

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen (REPAIR)

Choroidal Neovascularisation

United Kingdom
ARCAGY/ GINECO GROUP

Completed

A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse (REV)

Ovarian Cancer Recurrent

France
Vitreous -Retina- Macula Consultants of New York
Genentech, Inc.

Completed

Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema

Retinal Vein Occlusion

United States
University Hospital, Bordeaux

Completed

Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple Myeloma (REVALLO)

Multiple Myeloma

France
Vitreous -Retina- Macula Consultants of New York
Genentech, Inc.

Withdrawn

Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration (SEIRA)

Age Related Macular Degeneration | CNV | AMD

United States
Institut de la Macula y la Retina
Centro Medico Teknon

Completed

FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration (FUSION)

Exudative Age-related Macular Degeneration

Spain
Mie University

Unknown

Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

Exudative Age-related Macular Degeneration

Japan
The New York Eye & Ear Infirmary
Genentech, Inc.

Completed

Treatment of Failing Blebs With Ranibizumab

Glaucoma, Open-Angle | Failing Bleb Following Trabeculectomy

United States
Maturi, Raj K., M.D., P.C.

Withdrawn

Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing

Persistent Diabetic Macular Edema

United States
Instituto de Olhos de Goiania

Unknown

Ranibizumab for Myopic Neovascularization

Myopic Choroidal Neovascularization

Brazil
California Retina Consultants
Genentech, Inc.

Completed

Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion

Central Retinal Vein Occlusion

United States
Oraya Therapeutics, Inc.

Unknown

Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

Age Related Macular Degeneration | Retinal Pigment Epithelial Detachment With Vascularization

Italy
Kresge Eye Institute
Wayne State University; Genentech, Inc.

Withdrawn

Ranibizumab for Neovascularization in Sickle Cell Retinopathy

Sickle Cell Anemia | Retinopathy

United States
The New York Eye Cancer Center
Genentech, Inc.

Completed

Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma

Radiation Retinopathy | Choroidal Melanoma

United States
Simcere Pharmaceutical Co., Ltd

Unknown

The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar

Advanced Primary Lung Adenocarcinoma

China
Hospital Universitari Vall d'Hebron Research Institute

Completed

Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus (ORDI-02)

Cutaneous Lupus

Spain
Novartis

Completed

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)

Japan
Medical University of Vienna

Unknown

Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type

MALT Lymphoma

Austria
Florida Academic Dermatology Centers
Celgene Corporation

Unknown

Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma (REvMM2009)

Cutaneous T Cell Lymphoma

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.

Age-Related Macular Degenerations. | Subfoveal Neovascularization.

United States
NCIC Clinical Trials Group

Completed

Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Sarcoma

Canada, United States
Qingdao Central Hospital

Recruiting

Chemotherapy Combines With Bevacizumab and PD-1 Inhibitor in Non-squamous NSCLC

PFS | OS

China
Ruihua Xu

Recruiting

Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma

China
Women's Hospital School Of Medicine Zhejiang University

Recruiting

Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy

Gestational Trophoblastic Neoplasia

China
Technische Universität Dresden

Completed

Bevacizumab Treatment and Retinal Vessel Monitoring (BevaRet)

Cancer

Germany
Samsung Medical Center

Completed

Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors

Refractory Solid Tumors

Korea, Republic of
Dana-Farber Cancer Institute

Completed

Sunitinib in Never-Smokers With Lung Adenocarcinoma

Lung Cancer

United States
Pfizer

Completed

Rollover Protocol for Prior SU011248 Protocols

Solid Tumors

United States, Australia, Italy, Greece, Sweden, Switzerland, United Kingdom, Canada, Singapore, France, Netherlands
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer

Endometrial Cancer

United States, Canada, Norway, United Kingdom, Australia
National Cancer Institute (NCI)

Completed

Flavopiridol in Treating Patients With Recurrent Prostate Cancer

Prostate Cancer

United States
Jaeb Center for Health Research
National Eye Institute (NEI); National Institutes of Health (NIH); Regeneron...

Completed

Anti-VEGF vs. Prompt Vitrectomy for VH From PDR (AB)

Proliferative Diabetic Retinopathy | Vitreous Hemorrhage

United States, Canada
Kim's Eye Hospital
Bayer

Completed

Intravitreal Aflibercept for Submacular Hemorrhage

Exudative Age-related Macular Degeneration

Korea, Republic of
National Cancer Institute (NCI)

Completed

VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Recurrent Melanoma | Stage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage III Melanoma | Extraocular Extension Melanoma

United States
Samsung Medical Center

Completed

Sunitinib as Second-line Treatment in Advanced Biliary Tract Carcinoma

Advanced Biliary Tract Adenocarcinoma

Korea, Republic of
Association Pour La Recherche des Thérapeutiques...

Completed

Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease (VHLSUT)

Von Hippel-Lindau Disease

France
Genor Biopharma Co., Ltd.

Unknown

Clinical Trial in Chinese Healthy Volunteers of GB222

Non-small Cell Lung Cancer

China

Search clinical trials for: Growth Inhibitors

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations